期刊文献+

尤瑞克林对脑缺血再灌注大鼠血管抑素表达的影响 被引量:1

Effect of urinary kallidinogenase on the expression of angiostatin in the brain tissue of the rats after cerebral ischemia reperfusion
下载PDF
导出
摘要 目的:观察尤瑞克林对脑缺血再灌注大鼠脑组织中血管抑素表达的影响。方法:选取成年雄性SD大鼠24只,将其随机分为假手术组、模型组和试验组。模型组和试验组大鼠制作大脑中动脉阻塞脑缺血再灌注模型。试验组于再灌注后5 min静脉注射尤瑞克林。再灌注3 d后采用Western blot检测脑组织中血管抑素的表达。结果:假手术组脑组织中可见血管抑素表达;模型组和试验组脑组织中血管抑素表达均明显高于假手术组,差异有统计学意义(P<0.05)。与模型组相比,试验组脑组织中血管抑素表达下降,差异具有统计学意义(P<0.05)。结论:尤瑞克林可降低血管抑素表达来促进血管新生而发挥脑保护作用。 Objective To study the effect of urinary kallidinogenase on the expression of angiostatin in rat brain tissue after focal cerebral ischemia reperfusion. Method Rats were randomly assigned into three groups: sham operation group,model group and test group. The middle cerebral artery occlusion reperfusion model was made by the suture method. The rats in the test group were injected with urinary kallidinogenase after making a model. The expression of angiostatin was detected by Western blot. Results The expression of angiostatin in brain tissue of sham operation group,the expression of angiostatin in brain tissue of model group and test group was higher than that of sham operation group,the difference was statistically significant(P〈0. 05).Compared with the model group,the angiostatin expression was downregulated in rats of the test group,the difference was statistically significant(P〈0. 05). Conclusion Urinary kallidinogenase can induce angiogenesis by down-regulating the expression of angiostatin.
出处 《吉林医学》 CAS 2016年第11期2616-2617,共2页 Jilin Medical Journal
基金 福建省卫生计生委青年科研课题[项目编号:2014-1-85]
关键词 尤瑞克林 脑缺血再灌注 血管抑素 Urinary kallidinogenase Cerebral ischemia reperfusion Angiostatin
  • 相关文献

参考文献3

二级参考文献31

  • 1O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel an- giogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma[ J]. Cell, 1994,79(2) :315 - 328.
  • 2Mofikawa W, Yamamoto K, Ishikawa S, et al. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells[ J]. J Biol Chem, 2000,275(49) :38912 -38920.
  • 3Gabison E, Chang JH, Hernandez-Quintela E, et al. Anti-angiogenie role of angiostatin during corneal wound healing [ J ]. Exp Eye Res, 2004,78(3) :579 -589.
  • 4Warejcka DJ, Vaughan KA, Bernstein AM, et al. Differential con- version of plasminogen to angiostatin by human corneal een popula- tions[J].Mol Vis, 2005,11:859 -868.
  • 5Stevenson W, Cheng SF, Dastjerdi NH, et al. Corneal Neovascular- ization and the Utility of Topical VEGF Inhibition: Ranibizumab( Lu- centis) Vs Bevacizumab (Avastin) [ J ]. Ocular Surface, 2012,10 (2) :67 -83.
  • 6Matsumoto G, Ohmi Y, Shindo J. Angiostatin gene therapy inhibits the growth of routine squamous cell carcinoma in vivo[ J ]. Oral On- col, 2001,37(4) :369 -378.
  • 7Tandle A, Blazer DG, 3rd, Libutti SK. Antiangiogenic gene therapy of cancer: recent developments [ J ]. J Transl Med, 2004,2 (1) :22.
  • 8Lai CC, Wu WC, Chen SL, et al. Recombinant adeno-associated vi- res vector expressing angiostatin inhibits preretinal neovascularization in adult rats[ J]. Ophthalmic Res, 2005,37 ( 1 ) :50 -56.
  • 9Meneses PI, Hajjar KA, Berns KI, et al. Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopa- thy model[J]. Gene Ther, 2001,8(8) :646 -648.
  • 10Drixler TA, Borel Rinkes IH, Ritchie ED, et al. Angiostatin inhib- its pathological but not physiological retinal angiogenesis[ J]. Invest Ophthalmol Vis Sei, 2001,42(13) :3325 -3330.

共引文献28

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部